Sign in

CIK 0000812796

  • Non-accelerated filer
  • Smaller reporting company

SOLIGENIX, INC.

Sign in to watch
Ticker
SNGX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
411505029
Phone
+1 609-538-8200
Business address
29 EMMONS DRIVE, SUITE B-10, PRINCETON, NJ, 08540
Former names
SOLIGENIX, INC., DOR BIOPHARMA INC, ENDOREX CORP, IMMUNOTHERAPEUTICS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2010-09-23 LAPOINTE ANTHONY GREGG Director Grant or award · Stock Option (Right to Buy) +187,500 187,500
2010-09-23 THOMPSON VIRGIL Director Grant or award · Stock Option (Right to Buy) +300,000 300,000
2010-09-23 HOWSON TAMAR D Director Grant or award · Stock Option (Right to Buy) +300,000 300,000
2010-08-18 BAM Management LLC 10% owner Purchase −160,000 $0.24 $38K 21,766,092
2010-08-18 BAM Management LLC 10% owner Sale −192,314 $0.24 $46K 21,573,778
2010-06-18 LAPOINTE ANTHONY GREGG Director Purchase +975,610 $0.21 $200K 975,610
2010-06-18 RUBIN ROBERT J. Director Purchase +243,902 $0.21 $50K 243,902
2010-06-18 CAVAZZA CLAUDIO 10% owner Purchase +8,608,580 $0.21 $1.8M 54,227,816
2010-06-18 CAVAZZA CLAUDIO 10% owner Other acquisition · Common Stock Warrant (warrant to buy) +1 1
2010-06-18 CAVAZZA PAOLO 10% owner Purchase +8,608,580 $0.21 $1.8M 54,227,816
2010-06-18 CAVAZZA PAOLO 10% owner Purchase +2,926,829 $0.21 $600K 3,282,929
2010-06-18 CAVAZZA PAOLO 10% owner Other acquisition · Common Stock Warrant (warrant to buy) +1 1
2010-06-18 CAVAZZA PAOLO 10% owner Other acquisition · Common Stock Warrant (warrant to buy) +1 1
2010-06-18 SIGMA TAU FINANZIARIA SPA 10% owner Purchase +8,608,580 $0.21 $1.8M 54,227,816
2010-06-18 SIGMA TAU FINANZIARIA SPA 10% owner Other acquisition · Common Stock Warrant (right to buy) +1 1
2009-10-09 Biotex Pharma Investments, LLC 10% owner Returned to the company −335,000 $0.32 $106K 17,665,000
2009-10-08 Rubin Robert Joseph Director Grant or award · Stock Options (right to buy) +300,000 300,000
2009-10-01 Biotex Pharma Investments, LLC 10% owner Returned to the company −750,000 $0.31 $232K 18,000,000
2009-09-28 Biotex Pharma Investments, LLC 10% owner Returned to the company −250,000 $0.26 $66K 18,750,000
2009-09-28 SCHABER CHRISTOPHER J Chief Executive Officer Purchase +79,051 $0.25 $20K 471,817

Page 15 of 22 · 422 trades